Trimech M, Letourneau A, Missiaglia E, De Prijck B, Nagy-Hulliger M, Somja J, Vivario M, Gaulard P, Lambert F, Bisig B, de Leval L (June 2021). "Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome". The American Journal of Surgical Pathology. 45 (6): 773–786. doi:10.1097/PAS.0000000000001646. hdl:2268/289883. PMID33739791. S2CID232301854.
Travis LB, Curtis RE, Hankey BF, Fraumeni JF (September 1992). "Second cancers in patients with chronic lymphocytic leukemia". Journal of the National Cancer Institute. 84 (18): 1422–7. doi:10.1093/jnci/84.18.1422. PMID1512794.
Soilleux EJ, Wotherspoon A, Eyre TA, Clifford R, Cabes M, Schuh AH (December 2016). "Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review". Histopathology. 69 (6): 1066–1076. doi:10.1111/his.13024. PMID27345622. S2CID205171057.
Lenartova A, Randen U, Johannesen TB, Tjønnfjord GE (June 2019). "Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway". Cancer Epidemiology. 60: 128–133. doi:10.1016/j.canep.2019.04.002. PMID30986631. S2CID116860926.
Elnair R, Ellithi M, Kallam A, Shostrom V, Bociek RG (October 2021). "Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database". Annals of Hematology. 100 (10): 2513–2519. doi:10.1007/s00277-021-04603-y. PMID34279675. S2CID236036443.
Ravindran A, Kurtin PJ, King RL, Yuan J, Feldman AL, Rech KL, McPhail ED, Parikh SA, Ding W, Shi M (July 2022). "Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma". Human Pathology. 125: 2–10. doi:10.1016/j.humpath.2022.04.004. PMID35421421. S2CID248143907.
Gamaleldin MA, Ghallab OM, Nadwan EA, Abo Elwafa RA (November 2021). "PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia". Clinical & Translational Oncology. 23 (11): 2309–2322. doi:10.1007/s12094-021-02657-y. PMID34120295. S2CID235419552.
Al-Sawaf O, Robrecht S, Bahlo J, Fink AM, Cramer P, V Tresckow J, Lange E, Kiehl M, Dreyling M, Ritgen M, Dürig J, Tausch E, Schneider C, Stilgenbauer S, Wendtner CM, Fischer K, Goede, Hallek M, Eichhorst B (January 2021). "Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials". Leukemia. 35 (1): 169–176. doi:10.1038/s41375-020-0797-x. PMID32203141. S2CID212742666.
handle.net
hdl.handle.net
Trimech M, Letourneau A, Missiaglia E, De Prijck B, Nagy-Hulliger M, Somja J, Vivario M, Gaulard P, Lambert F, Bisig B, de Leval L (June 2021). "Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome". The American Journal of Surgical Pathology. 45 (6): 773–786. doi:10.1097/PAS.0000000000001646. hdl:2268/289883. PMID33739791. S2CID232301854.
Trimech M, Letourneau A, Missiaglia E, De Prijck B, Nagy-Hulliger M, Somja J, Vivario M, Gaulard P, Lambert F, Bisig B, de Leval L (June 2021). "Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome". The American Journal of Surgical Pathology. 45 (6): 773–786. doi:10.1097/PAS.0000000000001646. hdl:2268/289883. PMID33739791. S2CID232301854.
Travis LB, Curtis RE, Hankey BF, Fraumeni JF (September 1992). "Second cancers in patients with chronic lymphocytic leukemia". Journal of the National Cancer Institute. 84 (18): 1422–7. doi:10.1093/jnci/84.18.1422. PMID1512794.
Soilleux EJ, Wotherspoon A, Eyre TA, Clifford R, Cabes M, Schuh AH (December 2016). "Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review". Histopathology. 69 (6): 1066–1076. doi:10.1111/his.13024. PMID27345622. S2CID205171057.
LORTHOLARY P, BOIRON M, RIPAULT P, LEVY JP, MANUS A, BERNARD J (1964). "Chronic Lymphoid Leukemia Secondarily Associated with a Malignant Reticulopathy: Richter's Syndrome". Nouvelle Revue Française d'Hématologie (in French). 4: 621–44. PMID14199493.
Lenartova A, Randen U, Johannesen TB, Tjønnfjord GE (June 2019). "Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway". Cancer Epidemiology. 60: 128–133. doi:10.1016/j.canep.2019.04.002. PMID30986631. S2CID116860926.
Elnair R, Ellithi M, Kallam A, Shostrom V, Bociek RG (October 2021). "Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database". Annals of Hematology. 100 (10): 2513–2519. doi:10.1007/s00277-021-04603-y. PMID34279675. S2CID236036443.
Ravindran A, Kurtin PJ, King RL, Yuan J, Feldman AL, Rech KL, McPhail ED, Parikh SA, Ding W, Shi M (July 2022). "Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma". Human Pathology. 125: 2–10. doi:10.1016/j.humpath.2022.04.004. PMID35421421. S2CID248143907.
Gamaleldin MA, Ghallab OM, Nadwan EA, Abo Elwafa RA (November 2021). "PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia". Clinical & Translational Oncology. 23 (11): 2309–2322. doi:10.1007/s12094-021-02657-y. PMID34120295. S2CID235419552.
Al-Sawaf O, Robrecht S, Bahlo J, Fink AM, Cramer P, V Tresckow J, Lange E, Kiehl M, Dreyling M, Ritgen M, Dürig J, Tausch E, Schneider C, Stilgenbauer S, Wendtner CM, Fischer K, Goede, Hallek M, Eichhorst B (January 2021). "Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials". Leukemia. 35 (1): 169–176. doi:10.1038/s41375-020-0797-x. PMID32203141. S2CID212742666.
Musanhu E, Sharma RK, Attygalle A, Wotherspoon A, Chau I, Cunningham D, Dearden C, El-Sharkawi D, Iyengar S, Sharma B (November 2021). "Chronic lymphocytic leukaemia and Richter's transformation: multimodal review and new imaging paradigms". Clinical Radiology. 76 (11): 789–800. doi:10.1016/j.crad.2021.06.001. PMID34217434. S2CID235733549.
Trimech M, Letourneau A, Missiaglia E, De Prijck B, Nagy-Hulliger M, Somja J, Vivario M, Gaulard P, Lambert F, Bisig B, de Leval L (June 2021). "Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome". The American Journal of Surgical Pathology. 45 (6): 773–786. doi:10.1097/PAS.0000000000001646. hdl:2268/289883. PMID33739791. S2CID232301854.
Soilleux EJ, Wotherspoon A, Eyre TA, Clifford R, Cabes M, Schuh AH (December 2016). "Diagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review". Histopathology. 69 (6): 1066–1076. doi:10.1111/his.13024. PMID27345622. S2CID205171057.
Lenartova A, Randen U, Johannesen TB, Tjønnfjord GE (June 2019). "Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway". Cancer Epidemiology. 60: 128–133. doi:10.1016/j.canep.2019.04.002. PMID30986631. S2CID116860926.
Elnair R, Ellithi M, Kallam A, Shostrom V, Bociek RG (October 2021). "Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database". Annals of Hematology. 100 (10): 2513–2519. doi:10.1007/s00277-021-04603-y. PMID34279675. S2CID236036443.
Ravindran A, Kurtin PJ, King RL, Yuan J, Feldman AL, Rech KL, McPhail ED, Parikh SA, Ding W, Shi M (July 2022). "Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma". Human Pathology. 125: 2–10. doi:10.1016/j.humpath.2022.04.004. PMID35421421. S2CID248143907.
Gamaleldin MA, Ghallab OM, Nadwan EA, Abo Elwafa RA (November 2021). "PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia". Clinical & Translational Oncology. 23 (11): 2309–2322. doi:10.1007/s12094-021-02657-y. PMID34120295. S2CID235419552.
Al-Sawaf O, Robrecht S, Bahlo J, Fink AM, Cramer P, V Tresckow J, Lange E, Kiehl M, Dreyling M, Ritgen M, Dürig J, Tausch E, Schneider C, Stilgenbauer S, Wendtner CM, Fischer K, Goede, Hallek M, Eichhorst B (January 2021). "Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials". Leukemia. 35 (1): 169–176. doi:10.1038/s41375-020-0797-x. PMID32203141. S2CID212742666.